Hepatocellular carcinoma (HCC) is the most common primary liver cancer which usually develops in the setting of liver cirrhosis. Curative treatment strategies for HCC involve tumor resection, liver transplantation or ablation. However, many patients present with advanced-stage disease or multifocal tumors which make them unsuitable for radical treatment options. In such cases, locoregional therapy (LRT) such as transarterial chemoembolization (TACE), transarterial radioembolization (TARE) can be…